Smith, Moore & Co. Pfizer Inc Transaction History
Smith, Moore & Co.
- $1.16 Billion
- Q4 2025
A detailed history of Smith, Moore & Co. transactions in Pfizer Inc stock. As of the latest transaction made, Smith, Moore & Co. holds 34,412 shares of PFE stock, worth $863,052. This represents 0.07% of its overall portfolio holdings.
Number of Shares
34,412
Previous 39,963
13.89%
Holding current value
$863,052
Previous $1.02 Million
15.23%
% of portfolio
0.07%
Previous 0.09%
Shares
34 transactions
Others Institutions Holding PFE
# of Institutions
3,389Shares Held
3.57BCall Options Held
86.6MPut Options Held
105M-
Vanguard Group Inc Valley Forge, PA541MShares$13.6 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY424MShares$10.6 Billion0.27% of portfolio
-
State Street Corp Boston, MA299MShares$7.5 Billion0.27% of portfolio
-
Geode Capital Management, LLC Boston, MA129MShares$3.24 Billion0.22% of portfolio
-
Morgan Stanley New York, NY74.8MShares$1.88 Billion0.12% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $141B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...